1.河南中医药大学药学院,郑州 450046
2.河南中医药大学中医药科学院,郑州 450046
Received:01 October 2025,
Revised:2026-02-10,
Accepted:10 February 2026,
Published:15 March 2026
移动端阅览
陈宇,黄胜楠,王子昂,等.藤黄酸智能响应脂质体-水凝胶纳米制剂的制备、表征及体外抗肿瘤活性研究 Δ[J].中国药房,2026,37(05):613-619.
CHEN Yu,HUANG Shengnan,WANG Ziang,et al.Preparation, characterization, and in vitro antitumor activity of Gambogic acid-loaded intelligent responsive liposome-hydrogel nanopreparation[J].ZHONGGUO YAOFANG,2026,37(05):613-619.
陈宇,黄胜楠,王子昂,等.藤黄酸智能响应脂质体-水凝胶纳米制剂的制备、表征及体外抗肿瘤活性研究 Δ[J].中国药房,2026,37(05):613-619. DOI: 10.6039/j.issn.1001-0408.2026.05.11.
CHEN Yu,HUANG Shengnan,WANG Ziang,et al.Preparation, characterization, and in vitro antitumor activity of Gambogic acid-loaded intelligent responsive liposome-hydrogel nanopreparation[J].ZHONGGUO YAOFANG,2026,37(05):613-619. DOI: 10.6039/j.issn.1001-0408.2026.05.11.
目的
2
制备藤黄酸(GA)智能响应脂质体-水凝胶纳米制剂,并对其进行表征和体外抗肿瘤活性研究。
方法
2
采用乙醇注入法结合冷溶法,将GA和光敏剂吲哚菁绿(ICG)联合制成智能响应脂质体-水凝胶纳米制剂(GA-ICG-Lip-gel)。观察GA-ICG-Lip-gel的外观形态和微观形态,测定其包封率和载药量,考察其光热转换性能、光热稳定性、红外成像性质,测定其体外释放度。以人源乳腺癌MCF-7细胞为研究对象,考察GA-ICG-Lip-gel(或结合近红外光照射)对细胞活力、迁移能力的影响以及细胞对GA-ICG-Lip-gel的摄取能力。
结果
2
GA-ICG-Lip-gel在室温下呈溶液状态,而在37 ℃下则为凝胶状态;其微观结构致密、孔隙较小,包封率为(96.07±0.86)%、载药量为(6.28±1.16)%;经近红外光照射后,GA-ICG-Lip-gel温度升至42 ℃以上,且升温曲线未出现明显衰减,升温效率同时依赖于照射时间与药物浓度;相比于不含明胶酶的介质,GA-ICG-Lip-gel在含明胶酶的介质中的累积释放率增加。体外实验结果显示,MCF-7细胞对GA-ICG-Lip-gel的摄取较强;GA-ICG-Lip-gel可显著抑制MCF-7细胞的活力和迁移能力(
P
<0.05),且该抑制作用在近红外光照射下更强。
结论
2
本研究成功制备GA-ICG-Lip-gel,该制剂具有良好的光热转换性能和温度/酶双重响应性释药特征,且对乳腺癌细胞的增殖、迁移具有显著的抑制作用。
OBJECTIVE
2
To prepare an intelligent responsive liposome-hydrogel nanopreparation co-loaded with gambogic acid (GA), and characterize its antitumor activity
in vitro
.
METHODS
2
GA-ICG-Lip-gel was prepared by ethanol injection and cold dissolution, incorporating GA and the photosensitizer indocyanine green (ICG). The appearance and microscopic morphology of GA-ICG-Lip-gel were observed, its encapsulation efficiency and drug loading capacity were measured, and its photothermal conversion performance, photothermal stability, and infrared imaging properties were investigated, along with the determination of its in vitro release profile. Human breast cancer MCF-7 cells were used as objects to investigate the effects of GA-ICG-Lip-gel (or with near-infrared light irradiation) on cell viability, migration ability, and the cellular uptake capacity of GA-ICG-Lip-gel.
RESULTS
2
GA-ICG-Lip-gel existed in a solution state at room temperature and transformed into a gel state at 37 ℃. Its microstructure was dense with small pores, and its encapsulation efficiency and drug loading were (96.07±0.86) % and (6.28±1.16) %, respectively. After exposure to near-infrared light, the temperature of GA-ICG-Lip-gel rose above 42 ℃, with no significant attenuation observed in the heating curve. The heating efficiency was dependent on both the irradiation time and drug concentration. Compared to media without gelatinase, the cumulative release rate of GA-ICG-Lip-gel increased in media containing gelatinase.
In vitro
studies showed that GA-ICG-Lip-gel could be efficiently taken up by MCF-7 cells; GA-ICG-Lip-gel significantly inhibited the viability and migration ability of MCF-7 cells (
P
<0.05), and this inhibitory effect was further enhanced under near-infrared light irradiation.
CONCLUSIONS
2
This study successfully prepares GA-ICG-Lip-gel, which exhibits favorable photothermal conversion properties and temperature/enzyme dual-responsive drug release characteristics, and demonstrates significant inhibitory effects on the proliferation and migration of breast cancer cells.
KIM J , HARPER A , MCCORMACK V , et al . Global patterns and trends in breast cancer incidence and mortality across 185 countries [J ] . Nat Med , 2025 , 31 ( 4 ): 1154 - 1162 .
ADWALL L , FREDRIKSSON I , HULTIN H , et al . Postoperative complications after breast cancer surgery and effect on recurrence and survival:population-based cohort study [J ] . BJS Open , 2024 , 8 ( 6 ): zrae137 .
OTTO-DOBOS L D , GRANT C V , LAHOUD A A , et al . Chemotherapy-induced gut microbiome disruption,inflammation,and cognitive decline in female patients with breast cancer [J ] . Brain Behav Immun , 2024 , 120 : 208 - 220 .
XIONG Y , RAO Y , HU J W , et al . Nanoparticle-based photothermal therapy for breast cancer noninvasive treatment [J ] . Adv Mater , 2025 , 37 ( 31 ): e2305140 .
ATTARIAN F , HATAMIAN G , NOSRATI S , et al . Role of liposomes in chemoimmunotherapy of breast cancer [J ] . J Drug Target , 2025 , 33 ( 6 ): 887 - 915 .
QIAO J X , GUO D Y , TIAN H , et al . Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer [J ] . Mater Today Bio , 2024 , 29 : 101358 .
MO C X , LUO R , CHEN Y P . Advances in the stimuli-responsive injectable hydrogel for controlled release of drugs [J ] . Macromol Rapid Commun , 2022 , 43 ( 10 ): e2200007 .
CHEN J H , YU H Y , ZHENG T T , et al . Recent advancements and perspectives of photoresponsive inorganic nanomaterials for cancer phototherapy and diagnosis [J ] . RSC Adv , 2025 , 15 ( 20 ): 15450 - 15475 .
XIE J H , TIAN S Y , ZHANG H N , et al . A novel NQO1 enzyme-responsive polyurethane nanocarrier for redox-triggered intracellular drug release [J ] . Biomacromo- lecules , 2023 , 24 ( 5 ): 2225 - 2236 .
WANG Y Y , LIU S Q , LU K Y , et al . Gambogic acid targets HSP90 to alleviate DSS-induced colitis via inhibiting the necroptosis of intestinal epithelial cells [J ] . Front Pharmacol , 2025 , 16 : 1586705 .
FAHMY S A , ELGHANAM R , RASHID G , et al . Emerging tendencies for the nano-delivery of gambogic acid:a promising approach in oncotherapy [J ] . RSC Adv , 2024 , 14 ( 7 ): 4666 - 4691 .
WANG C Y , LAN X Y , ZHU L J , et al . Construction stra- tegy of functionalized liposomes and multidimensional application [J ] . Small , 2024 , 20 ( 25 ): e2309031 .
SUN W L , HE W F . Application of liposome-based drug delivery systems in tumor treatment [J ] . J Clust Sci , 2025 , 36 ( 4 ): 118 .
张梓怡 , 沈奇英 . 温敏原位凝胶在不同给药途径中的应用进展 [J ] . 杭州师范大学学报(自然科学版) , 2025 , 24 ( 6 ): 561 - 570 .
潘罗星 , 赵一曼 , 袁慧 , 等 . Box-Behnken响应面法对比GA-BP神经网络优化知母盐炙工艺 [J ] . 中国药房 , 2025 , 36 ( 19 ): 2399 - 2403 .
李溯 , 王清华 , 达梦婷 , 等 . 藤黄酸下调蛋白C受体表达杀伤三阴性乳腺癌干细胞的作用机制 [J ] . 中国组织工程研究 , 2025 , 29 ( 23 ): 4888 - 4898 .
涂柯蓉 , 杨尚沁 , 徐琦琦 , 等 . 藤黄酸药理作用机制与毒理学研究进展 [J ] . 中国中药杂志 , 2024 , 49 ( 24 ): 6593 - 6603 .
LUO M F , OOMAH B D , AKOETEY W , et al . Liposomes as sustainable delivery systems in food,cosmetic,and pharmaceutical applications [J ] . J Am Oil Chem Soc , 2025 , 102 ( 3 ): 547 - 568 .
项舒婷 . 藤黄酸-吲哚菁绿无载体靶向纳米体系的构建及其用于成像介导的肿瘤联合治疗研究 [D ] . 泉州 : 华侨大学 , 2020 .
PEREIRA A K V , DE MELO BARBOSA R , FERNANDES M A C , et al . Comparative analyses of response surface methodology and artificial neural networks on incorporating tetracaine into liposomes [J ] . Braz J Pharm Sci , 2020 , 56 : e17808 .
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
